Month: September 2024

Wytec“Preventing the Unthinkable”SAN ANTONIO, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) — Wytec International, Inc. (OTCQB: WYTC), an Artificial Intelligence (AI) 5G company, announced today the commencement of its SEC 506(c) 9.5% $10,000,000 Convertible Secured Note Offering (Secured by its Patents), utilized to complete the funding of its AI Gunshot/Sensor technology in support of protecting America’s children from increased shooter violence and detecting harmful drugs infiltrating U.S. Independent School Districts (ISDs) across America and Internationally. The AI/Sensor technology includes the engagement of multiple national and international vendors participating in the Company’s Pilot Project in support of 40 Texas ISDs requesting to participate in Wytec’s pilot program.  “The Company’s initial lab results (over...

ENGLEWOOD CLIFFS, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) — Atlantic International Corp. (“Atlantic”) (OTC: ATLN), a leading provider of strategic staffing outsourced services and workforce solutions, today announced a new location in Temple, TX for its subsidiary Lyneer Staffing Solutions, marking a significant milestone in the company’s strategic expansion. This latest addition to Lyneer’s network will support a leading industrial automation company. It underscores Lyneer’s commitment to forging partnerships with key industry players and reinforcing its dedication to providing cutting-edge workforce solutions that optimize productivity and fuel client growth. Lyneer Staffing Solutions’ CEO, Todd McNulty, commented on the expansion: “Our new Temple, TX location represents a pivotal step in strengthening our regional...

BETHESDA, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) — iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines” or “ILE”) a leader in AI-powered learning and work automation for enterprises, today announced that the Company’s Board of Directors has formed a Special Committee consisting of independent directors to investigate allegations raised recently by a short-seller report. The Special Committee has engaged legal counsel from Paul Hastings LLP to conduct an independent investigation at the behest and exclusive direction of the Special Committee. Although the Company’s independent auditors conduct periodic audits in accordance with PCAOB standards and have issued clean audit opinions with respect to their past audits, the Special Committee believes that conducting its own independent investigation into these issues is in the best...

MIAMI, Sept. 05, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announced that it was awarded conditional approval to serve as a pharmaceutical processor by the Virginia Cannabis Control Authority (“CCA”) for Virginia’s Health Service Area 1 (“HSA 1”). HSA 1 encompasses various cities and counties in Virginia, including Charlottesville, Fredericksburg, Spotsylvania, and Stafford. “We’re proud to have earned the opportunity to serve patients in Virginia, particularly in a region of ~1.5 million people that has lacked access to medical cannabis for some time,” said David Goubert, President & CEO of AYR. “This is an exciting moment for AYR, reflective of our continued efforts towards building our business...

REDMOND, Wash., Sept. 05, 2024 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, announced the closing of its previously announced public offering with net proceeds to the Company of approximately $7.04 million, after deducting placement agent fees and offering expenses. The offering consisted of 2,882,883 shares of its common stock and warrants to purchase up to an aggregate of 2,882,883 shares of its common stock at a combined public offering price $2.775 per share and associated common warrant in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock was sold together with one warrant to purchase one share of common stock. The warrants have an exercise price of...

Key PointsImmuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical trial data on IMM-529 provides support for continued development of IMM-529 Investigational new drug (IND) application for IMM-529 planned for 1H 2025MELBOURNE, Australia, Sept. 05, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has received favourable feedback from the United States Food and Drug Administration (FDA) on the pre-IND (investigational new drug) information package to support the clinical development of IMM-529. Following the FDA’s guidance and feedback, the Company now plans to file an investigational new drug...